US 10654874
Heterocyclic compound and use thereof
granted A61PA61P25/00A61P25/14
Quick answer
US patent 10654874 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/18, A61P25/20